Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Cefpiramide Sodium for Injection

Approval Number

国药准字HJ20160327

CompanyYuhan Corporation

Registration Date

October 25, 2024

Previous Approval Numbers

H20160327

Drug Information

Generic Name

注射用头孢匹胺钠

Trade Name

先福吡兰

Dosage Form

注射剂

Strength

1.0g

Drug Type

化学药品

Registration Date

October 25, 2024

Expiry Date

October 24, 2029

Company Information

Applicant Company

Company NameYuhan Corporation

Company Address

219 , Yeongudan ji-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea

Manufacturing Company

Company NameYuhan Corporation

Company Address

219，Yeongudan ji-ro, Ochang-eup, Cheongwon-gu, Cheong ju-si, Chungcheongbuk-do, Republic of Korea

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用头孢匹胺钠 - NMPA 批准文号 | MedPath